Emergent BioSolutions Inc. (EBS)

Latest Insider Confidence Score

2026Q1

44.4
Bearish

Company insider confidence (by quarter)

2013Q1 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
El-Hibri Fuad Chair 1,136,971 Dec 7, 2021
Mulligan Seamus — 545,590 Mar 21, 2019
Papa Joseph C CEO 342,500 May 15, 2025
Lindahl Richard S CFO 291,497 Oct 17, 2025
Fox Jennifer Lynne EVP, Ext Aff, GC, Corp Sec 186,382 Jul 12, 2024

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
May 7, 2025 Mar 6, 2026 LINDAHL RICHARD S CFO Neutral 52.5 - 0.00% ✗ -
Mar 5, 2026 Mar 5, 2026 PAPA JOSEPH C CEO Sell 20.0 -37,055 -10.82% ✗ $312.7K
Mar 3, 2026 Mar 5, 2026 FOWLER JOHN D JR Director Neutral 90.0 +5,006 100.00% ✗ -
Mar 5, 2026 FOWLER JOHN D JR Director Neutral 52.5 - 0.00% ✗ -
Mar 5, 2026 Mar 5, 2026 Lowry Simon C SVP, R&D, CMO Sell 22.5 -10,636 -12.03% ✗ $89.8K
Mar 5, 2026 Mar 5, 2026 Hartzel William SVP, Bioservices Sell 22.5 -9,493 -9.82% ✗ $80.1K
Mar 5, 2026 Mar 5, 2026 Perl Jessica SVP, General Counsel, Corp Sec Sell 22.5 -6,465 -9.58% ✗ $54.6K
Mar 5, 2026 Mar 5, 2026 Williams Paul Anthony SVP, Products Business Sell 22.5 -9,397 -12.35% ✗ $79.3K
Mar 5, 2026 Mar 5, 2026 LINDAHL RICHARD S CFO Sell 22.5 -23,650 -9.89% ✗ $199.6K
Mar 5, 2026 Mar 5, 2026 Glessner Coleen EVP, Quality & Ethics, and CPL Sell 22.5 -8,199 -7.30% ✗ $69.2K
Mar 1, 2026 Mar 3, 2026 Williams Paul Anthony SVP, Products Business Sell 52.5 -116 -0.15% ✗ $945.4
Mar 1, 2026 Mar 3, 2026 LINDAHL RICHARD S CFO Sell 45.0 -683 -0.28% ✗ $5.6K
Mar 1, 2026 Mar 3, 2026 Glessner Coleen EVP, Quality & Ethics, and CPL Sell 45.0 -313 -0.28% ✗ $2.6K
Feb 9, 2026 Feb 10, 2026 Perl Jessica SVP, General Counsel, Corp Sec Sell 26.3 -918 -1.34% ✗ $10.1K
Feb 6, 2026 Feb 10, 2026 Glessner Coleen EVP, Quality & Ethics, and CPL Sell 20.0 -31,699 -21.96% ✗ $346.2K
Feb 6, 2026 Feb 10, 2026 Williams Paul Anthony SVP, Products Business Sell 22.5 -9,677 -11.27% ✗ $105.7K
Feb 6, 2026 Feb 10, 2026 Hartzel William SVP, Bioservices Sell 22.5 -6,401 -6.21% ✗ $69.9K
Feb 6, 2026 Feb 10, 2026 LINDAHL RICHARD S CFO Sell 20.0 -51,797 -17.77% ✗ $565.6K
Dec 14, 2025 Dec 16, 2025 Lowry Simon C SVP, R&D, CMO Sell 26.3 -3,543 -3.85% ✗ $40.4K
Dec 5, 2025 Dec 9, 2025 Richard Ronald Director Sell 20.0 -32,848 -9.58% ✗ $392.3K
Nov 11, 2025 Nov 13, 2025 Hartzel William SVP, Bioservices Sell 37.5 -610 -0.59% ✗ $6.6K
Nov 10, 2025 Nov 12, 2025 DeGolyer Donald W Director Sell 25.0 -17,801 -12.93% ✓ $187.6K
Nov 7, 2025 Nov 10, 2025 Dayal Sujata Tyagi Director Sell 28.8 -8,552 -8.77% ✓ $85.5K
Oct 15, 2025 Oct 17, 2025 LINDAHL RICHARD S CFO Sell 26.3 -4,995 -1.68% ✗ $48K
Oct 7, 2025 Oct 16, 2025 Glessner Coleen EVP, Quality & Ethics, and CPL Sell 17.5 -30,608 -17.50% ✓ $306.1K
Aug 15, 2025 Aug 18, 2025 Zoon Kathryn C Director Sell 28.8 -7,086 -8.98% ✓ $62.9K
Aug 12, 2025 Aug 13, 2025 DeGolyer Donald W Director Sell 22.5 -7,844 -5.39% ✗ $67.8K
Jul 11, 2025 Jul 15, 2025 Hartzel William SVP, Bioservices Sell 26.3 -4,263 -3.95% ✗ $31.4K
Jun 8, 2025 Jun 10, 2025 Hartzel William SVP, Bioservices Sell 27.5 -1,167 -1.07% ✗ $7.7K
Jun 8, 2025 Jun 10, 2025 Glessner Coleen EVP, Quality & Ethics, and CPL Sell 37.5 -1,249 -0.71% ✗ $8.3K
Jun 8, 2025 Jun 10, 2025 Williams Paul Anthony SVP, Products Business Sell 37.5 -464 -0.54% ✗ $3.1K
Jun 8, 2025 Jun 10, 2025 LINDAHL RICHARD S CFO Sell 36.3 -2,733 -0.91% ✗ $18.1K
May 23, 2025 May 28, 2025 Katkin Keith Director Sell 32.5 -7,844 -8.32% ✓ $49.4K
May 13, 2025 May 15, 2025 PAPA JOSEPH C CEO Buy 97.5 +60,000 21.24% ✗ $349.8K
Apr 30, 2025 May 2, 2025 Richard Ronald Director Neutral 90.0 +34,403 48.38% ✗ -
Apr 30, 2025 May 2, 2025 White Marvin L Director Neutral 90.0 +34,403 63.60% ✗ -
Apr 30, 2025 May 2, 2025 Fowler Neal Franklin Director Neutral 90.0 +34,403 34.03% ✗ -
Apr 30, 2025 May 2, 2025 Zoon Kathryn C Director Neutral 90.0 +34,403 77.34% ✗ -
Apr 30, 2025 May 2, 2025 Dayal Sujata Tyagi Director Neutral 90.0 +34,403 54.50% ✗ -
Apr 30, 2025 May 2, 2025 Katkin Keith Director Neutral 90.0 +34,403 57.46% ✗ -
Apr 30, 2025 May 2, 2025 Harsanyi Zsolt Chair Neutral 90.0 +34,403 38.51% ✗ -
Apr 30, 2025 May 2, 2025 DeGolyer Donald W Director Neutral 90.0 +34,403 30.97% ✗ -
Apr 30, 2025 May 2, 2025 SULLIVAN LOUIS W Director Neutral 90.0 +34,403 32.86% ✗ -
Apr 7, 2025 Apr 9, 2025 Hartzel William SVP, Bioservices Sell 37.5 -561 -0.51% ✗ $2.5K
Apr 7, 2025 Apr 9, 2025 Glessner Coleen EVP, Quality & Ethics, and CPL Sell 45.0 -480 -0.27% ✗ $2.1K
Mar 6, 2025 Apr 9, 2025 Hartzel William SVP, Bioservices Neutral 90.0 +62,500 132.46% ✗ -
Mar 12, 2025 Mar 12, 2025 Fowler Neal Franklin Director Sell 22.5 -35,000 -25.72% ✗ $204.1K
Mar 12, 2025 Mar 12, 2025 Zoon Kathryn C Director Sell 22.5 -10,000 -18.35% ✗ $57.3K
Mar 12, 2025 Mar 12, 2025 PAPA JOSEPH C CEO Neutral 52.5 - 0.00% ✗ -
Mar 6, 2025 Mar 10, 2025 Perl Jessica SVP, General Counsel, Corp Sec Neutral 90.0 +62,500 1061.66% ✗ -
Mar 6, 2025 Mar 10, 2025 Williams Paul Anthony SVP, Products Business Neutral 90.0 +62,500 262.22% ✗ -
Mar 6, 2025 Mar 10, 2025 LINDAHL RICHARD S CFO Neutral 90.0 +146,888 96.42% ✗ -
Mar 6, 2025 Mar 10, 2025 Lowry Simon C SVP, R&D, CMO Neutral 90.0 +62,500 211.99% ✗ -
Mar 6, 2025 Mar 10, 2025 Hartzel William SVP, Bioservices Neutral 90.0 +62,500 131.65% ✗ -
Mar 6, 2025 Mar 10, 2025 PAPA JOSEPH C CEO Neutral 90.0 +282,500 100.00% ✗ -
Mar 6, 2025 Mar 10, 2025 Glessner Coleen EVP, Quality & Ethics, and CPL Neutral 90.0 +62,500 54.75% ✗ -
Mar 5, 2025 Mar 7, 2025 Hartzel William SVP, Bioservices Sell 37.5 -292 -0.62% ✗ $1.7K
Feb 12, 2025 Mar 4, 2025 Glessner Coleen EVP, Quality & Ethics, and CPL Sell 27.5 -30,304 -20.98% ✗ $2.3K
Feb 28, 2025 Mar 4, 2025 Williams Paul Anthony SVP, Products Business Sell 27.5 -498 -2.05% ✗ $3.7K
Feb 12, 2025 Mar 4, 2025 LINDAHL RICHARD S CFO Sell 26.3 -18,672 -10.92% ✗ $13.1K
Feb 9, 2025 Feb 11, 2025 Perl Jessica SVP, General Counsel, Corp Sec Sell 27.5 -918 -13.49% ✗ $9.2K
Dec 15, 2024 Dec 17, 2024 Lowry Simon C SVP, R&D, CMO Neutral 90.0 +29,482 100.00% ✗ -
Dec 8, 2024 Dec 10, 2024 Glessner Coleen EVP, Quality & Ethics, and CPL Sell 22.5 -18,674 -11.45% ✗ $168.3K
Nov 21, 2024 Lowry Simon C SVP, R&D, CMO Neutral 52.5 - 0.00% ✗ -
Nov 12, 2024 Nov 14, 2024 DeGolyer Donald W Director Sell 20.0 -25,000 -18.37% ✗ $272.8K
Nov 11, 2024 Nov 13, 2024 White Marvin L Director Sell 22.5 -14,287 -20.89% ✗ $171K
Nov 11, 2024 Nov 13, 2024 Hartzel William SVP, Bioservices Sell 27.5 -632 -1.31% ✗ $7.6K
Nov 12, 2024 Perl Jessica SVP, General Counsel, Corp Sec Neutral 52.5 - 0.00% ✗ -
Oct 15, 2024 Oct 17, 2024 LINDAHL RICHARD S CFO Neutral 85.0 +15,000 9.61% ✗ -
Jul 11, 2024 Jul 12, 2024 Hartzel William SVP, Bioservices Neutral 90.0 +15,000 45.31% ✗ -
Jul 11, 2024 Jul 12, 2024 Fox Jennifer Lynne EVP, Ext Aff, GC, Corp Sec Neutral 85.0 +15,000 8.75% ✗ -
Jul 8, 2024 Jul 10, 2024 Williams Paul Anthony SVP, Products Business Sell 45.0 -85 -0.35% ✗ $691.1
Jun 8, 2024 Jun 11, 2024 Fox Jennifer Lynne EVP, Ext Aff, GC, Corp Sec Sell 26.3 -2,376 -1.37% ✗ $14.7K
Jun 8, 2024 Jun 11, 2024 Williams Paul Anthony SVP, Products Business Sell 27.5 -464 -1.86% ✗ $2.9K
Jun 8, 2024 Jun 11, 2024 Glessner Coleen EVP, Quality & Ethics, and CPL Sell 37.5 -1,249 -0.76% ✗ $7.7K
Jun 8, 2024 Jun 11, 2024 LINDAHL RICHARD S CFO Sell 26.3 -2,733 -1.72% ✗ $16.9K
Jun 8, 2024 Jun 11, 2024 Hartzel William SVP, Bioservices Sell 27.5 -1,167 -3.40% ✗ $7.2K
Jun 4, 2024 Jun 6, 2024 Zoon Kathryn C Director Sell 22.5 -10,000 -15.51% ✗ $61.1K
May 29, 2024 May 31, 2024 Zoon Kathryn C Director Sell 27.5 -1,830 -2.76% ✗ $8.4K
May 23, 2024 May 28, 2024 Katkin Keith Director Neutral 90.0 +17,430 41.07% ✗ -
May 23, 2024 May 28, 2024 Fowler Neal Franklin Director Neutral 90.0 +17,430 14.69% ✗ -
May 23, 2024 May 28, 2024 DeGolyer Donald W Director Neutral 90.0 +17,430 14.69% ✗ -
May 23, 2024 May 28, 2024 White Marvin L Director Neutral 90.0 +17,430 34.21% ✗ -
May 23, 2024 May 28, 2024 Dayal Sujata Tyagi Director Neutral 90.0 +17,430 38.14% ✗ -
May 23, 2024 May 28, 2024 SULLIVAN LOUIS W Director Neutral 90.0 +17,430 19.97% ✗ -
May 23, 2024 May 28, 2024 Harsanyi Zsolt Chair Neutral 90.0 +17,430 24.24% ✗ -
May 23, 2024 May 28, 2024 Zoon Kathryn C Director Neutral 90.0 +17,430 35.66% ✗ -
May 23, 2024 May 28, 2024 Richard Ronald Director Neutral 90.0 +17,430 32.47% ✗ -
May 21, 2024 May 23, 2024 Zoon Kathryn C Director Sell 27.5 -1,089 -2.18% ✗ $6.3K
Apr 7, 2024 Apr 9, 2024 Glessner Coleen EVP, Quality & Ethics, and CPL Sell 45.0 -585 -0.35% ✗ $1.3K
Apr 7, 2024 Apr 9, 2024 Hartzel William SVP, Bioservices Sell 27.5 -665 -1.90% ✗ $1.5K
Mar 13, 2024 Mar 15, 2024 PAPA JOSEPH C CEO Neutral 52.5 - 0.00% ✗ -
Mar 13, 2024 Mar 15, 2024 Williams Paul Anthony SVP, Products Business Neutral 52.5 - 0.00% ✗ -
Mar 13, 2024 Mar 15, 2024 Glessner Coleen EVP, Quality & Ethics, and CPL Neutral 52.5 - 0.00% ✗ -
Mar 13, 2024 Mar 15, 2024 Fox Jennifer Lynne EVP, Ext Aff, GC, Corp Sec Neutral 52.5 - 0.00% ✗ -
Mar 13, 2024 Mar 15, 2024 LINDAHL RICHARD S CFO Neutral 52.5 - 0.00% ✗ -
Mar 13, 2024 Mar 15, 2024 Hartzel William SVP, Bioservices Neutral 52.5 - 0.00% ✗ -
Mar 5, 2024 Mar 7, 2024 Hartzel William SVP, Bioservices Sell 37.5 -346 -0.98% ✗ $1.2K
Mar 1, 2024 Mar 4, 2024 Glessner Coleen EVP, Quality & Ethics, and CPL Sell 45.0 -381 -0.23% ✗ $1.3K
Feb 29, 2024 Mar 4, 2024 Williams Paul Anthony SVP, Products Business Sell 27.5 -587 -2.30% ✗ $1.9K